Clinical Trial Update: Prognostic Value of Plasma DPP4 Activity in ST-elevation Myocardial Infarction Patients

View source ↗

Summary

This clinical trial update investigates the prognostic value of plasma DPP4 activity in patients with ST-segment elevation myocardial infarction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-segment Elevation Myocardial Infarction

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Coronary Angiography, Dipeptidyl Peptidase 4 | Status: COMPLETED